Announced
Completed
Financials
Tags
generic intermediates sale
generic intermediates production
generic intermediates development
active pharmaceutical ingredients sale
active pharmaceutical ingredients production
active pharmaceutical ingredients development
Pharmaceuticals
Singapore
Private
Disposal
Single Bidder
Friendly
Completed
Private Equity
Synopsis
Bain Capital acquired DSM Sinochem Pharmaceuticals, a 50/50 Joint Venture of Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, and Sinochem Group for £443m. “DSP is a market leader with an international reputation for high quality products and reliability,” said Benjamin Kunstler, a Managing Director at Bain Capital Private Equity. “We believe that DSP has tremendous potential to grow organically and through acquisitions, thanks to its strong production technology, product quality, and its focus on providing pharmaceutical customers with reliable solutions to their increasingly complex supply chains. We look forward to partnering with the management team to support the company in this new stage of its development.”
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.